helix chemical supply semaglutide | GLP-1 Receptor Agonist | CAS 910463-68-2 Semaglutide GLP-1 Receptor Agonist Research
Description
rheumatoid or psoriatic arthritis)
(7) GST
Semaglutide has a longer clinical track record, more complete long-term safety data, and an approved oral formulation
So far only one oral GLP-1 has appeared on the market, in 2019
Potential Side Effects While generally safe, some users may experience: Nausea & Vomiting (common at the beginning) Diarrhea or Constipation Fatigue Low Blood Sugar (Hypoglycemia) Injection Site Reactions If severe side effects occur, consult your healthcare provider immediately
It emulates the function of incretin hormone glucagon-like peptide-1 (GLP-1) found in the human body
